Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.40 is 56% below its 5-year average of 0.92, near the low end of its 5-year range (0.29–3.23).
As of the fiscal period ended Tuesday, June 30, 2026. 4.33% below its 12-month average of 0.42.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.40.
QUICK RATIO (ACID-TEST)
0.40
QUICK RATIO (ACID-TEST) AVG TTM
0.42
QUICK RATIO (ACID-TEST) AVG 3Y
0.88
QUICK RATIO (ACID-TEST) AVG 5Y
0.92
QUICK RATIO (ACID-TEST) AVG 10Y
0.72
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-4.33%
CURRENT VS 3Y AVG
-54.04%
CURRENT VS 5Y AVG
-56.38%
CURRENT VS 10Y AVG
-43.91%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 727 covered companies
CURRENT VS SECTOR MEDIAN
-87.38%
vs the sector median at left
Jaguar Health, Inc.
Market Cap
$2.55M
Quick Ratio (Acid-Test)
0.40
TTM Avg
0.42
3Y Avg
0.88
5Y Avg
0.92
Market Cap
$2.57M
Quick Ratio (Acid-Test)
1.41
TTM Avg
1.72
3Y Avg
3.92
5Y Avg
2.64
Market Cap
$2.47M
Quick Ratio (Acid-Test)
2.64
TTM Avg
2.37
3Y Avg
1.52
5Y Avg
1.27
Market Cap
$2.43M
Quick Ratio (Acid-Test)
0.94
TTM Avg
1.19
3Y Avg
3.93
5Y Avg
6.93
Market Cap
$2.37M
Quick Ratio (Acid-Test)
2.14
TTM Avg
0.35
3Y Avg
1.93
5Y Avg
12.75
Market Cap
$2.39M
Quick Ratio (Acid-Test)
12.73
TTM Avg
22.34
3Y Avg
19.49
5Y Avg
14.70
Market Cap
$2.30M
Quick Ratio (Acid-Test)
1.54
TTM Avg
2.65
3Y Avg
3.41
5Y Avg
4.73
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jaguar Health, Inc. (JAGX) | $2.55M | 0.40 | 0.42 | 0.88 | 0.92 |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.57M | 1.41 | 1.72 | 3.92 | 2.64 |
| Nuwellis, Inc. (NUWE)vs › | $2.59M | 1.54 | 1.94 | 2.53 | 3.69 |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.47M | 2.64 | 2.37 | 1.52 | 1.27 |
| iSpecimen Inc. (ISPC)vs › | $2.64M | 0.82 | 0.87 | 1.93 | 3.50 |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.43M | 0.94 | 1.19 | 3.93 | 6.93 |
| Onconetix, Inc. (ONCO)vs › | $2.37M | 2.14 | 0.35 | 1.93 | 12.75 |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.39M | 12.73 | 22.34 | 19.49 | 14.70 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.30M | 1.54 | 2.65 | 3.41 | 4.73 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.00M | 1.15 | 2.58 | 1.43 | 2.20 |
Quick Ratio
0.40
Excludes inventory
Current Ratio
0.69
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.40 |
| 2026-03-31 | 0.30 |
| 2025-12-31 | 0.29 |
| 2025-09-30 | 0.52 |
| 2025-06-30 | 0.59 |
| 2025-03-31 | 0.70 |
| 2024-12-31 | 1.11 |
| 2024-09-30 | 1.36 |
| 2024-06-30 | 1.60 |
| 2024-03-31 | 1.39 |
| 2023-12-31 | 1.34 |
| 2023-09-30 | 1.10 |
| 2023-06-30 | 0.69 |
| 2023-03-31 | 0.76 |
| 2022-12-31 | 0.50 |
| 2022-09-30 | 0.69 |
| 2022-06-30 | 0.73 |
| 2022-03-31 | 1.24 |
| 2021-12-31 | 1.52 |
| 2021-09-30 | 1.63 |
| 2021-06-30 | 3.23 |
| 2021-03-31 | 3.28 |
| 2020-12-31 | 1.14 |
| 2020-09-30 | 0.33 |
| 2020-06-30 | 0.37 |
| 2020-03-31 | 0.25 |
| 2019-12-31 | 0.48 |
| 2019-09-30 | 0.61 |
| 2019-06-30 | 0.24 |
| 2019-03-31 | 0.18 |
| 2018-12-31 | 0.18 |
| 2018-09-30 | 0.31 |
| 2018-06-30 | 0.33 |
| 2018-03-31 | 0.91 |
| 2017-12-31 | 0.11 |
| 2017-09-30 | 0.15 |
| 2017-06-30 | 0.34 |
| 2017-03-31 | 0.26 |
| 2016-12-31 | 0.51 |
| 2016-09-30 | 1.23 |
| 2016-06-30 | 1.61 |
| 2016-03-31 | 2.13 |
| 2015-12-31 | 2.10 |
| 2015-09-30 | 2.84 |
| 2015-06-30 | 4.58 |
| 2015-03-31 | 0.40 |
| 2014-12-31 | 1.68 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 4.19 |
| 2014-03-31 | 0.00 |